← Back to Search

Behavioral Intervention

iPeer2Peer Mentorship for Teen Heart Failure (iP2P HF Trial)

N/A
Recruiting
Led By Samantha J Anthony, PhD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Mentor: heart failure patient, between the ages of 18 and 25 years, able to speak and read English, nominated by a member of their health care team as a good mentor based on maturity and emotional stability, willingness to commit to peer mentor training (20 hours) via the PHIPA-compliant version of Zoom or Microsoft Teams and mentoring adolescent participants (once paired with mentee, 5-10 texts and/or calls of 20-30 minutes over a period of 15 weeks), good communication skills (as assessed by a healthcare provider), previous experience in a professional environment (e.g., as a camp counsellor, part time job, volunteering) is an asset.
Mentee: heart failure patient, at least 4 months post-diagnosis, between the ages of 12 and 17 years, able to speak and read English, willingness to commit to 5-10 texts and/or calls of 20-30 minutes each with a peer mentor over a period of 15 weeks.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study completion, an average of 1 year
Awards & highlights

iP2P HF Trial Summary

This trial will explore the effectiveness of a young adult peer mentor program to improve self-management skills of adolescents with chronic diseases.

Who is the study for?
This trial is for teens with heart failure aged 12-17 who are at least 4 months post-diagnosis, and young adults aged 18-25 as mentors. Mentees must commit to regular communication with a mentor over 15 weeks. Mentors need good communication skills, emotional stability, and willingness to train and support mentees. Excluded are those in other peer programs or with significant cognitive impairments or active psychological disorders.Check my eligibility
What is being tested?
The iP2P program is being tested to see if it helps teen heart failure patients manage their condition better through online peer mentorship. Participants will be randomly assigned to start the program immediately or after a waiting period (waitlist). They'll use video calls and texts for support over a period of 15 weeks.See study design
What are the potential side effects?
Since this trial involves an educational intervention rather than medication, traditional physical side effects aren't expected. However, participants may experience emotional discomfort due to discussing personal health issues.

iP2P HF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18-25, speak English, and can mentor a heart failure patient online.
Select...
I am a teen with heart failure, willing to communicate regularly with a mentor.

iP2P HF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability (Mentees)
Acceptability (Mentors)
Adoption (Mentees)
+7 more
Secondary outcome measures
Adherence (Mentees)
Assessment of mentor quality (Mentees)
Disease self-management skills (Mentees)
+7 more

iP2P HF Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iPeer2Peer ProgramExperimental Treatment1 Intervention
Group II: Standard of Care Waitlist Control GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

The Centre Hospitalier Universitaire Sainte-JustineUNKNOWN
University of Alberta/Stollery Children's HospitalUNKNOWN
1 Previous Clinical Trials
34 Total Patients Enrolled
British Columbia Children's HospitalOTHER
25 Previous Clinical Trials
15,176 Total Patients Enrolled

Media Library

iPeer2Peer Program (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05709132 — N/A
Heart Failure Research Study Groups: Standard of Care Waitlist Control Group, iPeer2Peer Program
Heart Failure Clinical Trial 2023: iPeer2Peer Program Highlights & Side Effects. Trial Name: NCT05709132 — N/A
iPeer2Peer Program (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05709132 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this experimental program?

"This trial, searching for a total of 55 participants, requires that applicants have heart failure and are between the ages of 12-25."

Answered by AI

Is the eligibility of this trial extending to those aged over 35?

"Inclusion requirements for this study mandates that potential participants are between the ages of 12 and 25. Meanwhile, there are 21 trials recruiting individuals below 18 years old, while 684 studies seek older adults over 65 years old."

Answered by AI

Are there currently openings for participants in this research?

"According to clinicaltrials.gov, this medical investigation is not presently recruiting participants. Initially posted on February 1st 2023, and recently updated on January 24th 2023, the study does not currently have any openings; however there are 696 other trials actively looking for candidates at present."

Answered by AI
~37 spots leftby Apr 2027